- Diabetes insipidus caused by ANCA associated vasculitis2022 | First Faculty of Medicine
- Plazmaferéza a glukokortikoidy u těžké ANCA asociované vaskulitidy2020 | First Faculty of Medicine
- Avacopan jako přídatná terapie ANCA asociované vaskulitidy2020 | First Faculty of Medicine
- Má mykofenolát mofetil místo v indukční léčbě ANCA asociované vaskulitidy?2019 | First Faculty of Medicine
- Exposure to silicon and ANCA-associated vasculitides +1Publication without faculty affiliation
- Alemtuzumab by refracting ANCA-associated vasculiltis2012 | First Faculty of Medicine
- Advantages of anti-myeloperoxidase and anti-proteinase-3 antibodies detection by chemiluminescence method in patients with ANCA-associated vasculitis2018 | First Faculty of Medicine
- Avacopan, inhibitor receptoru pro složku C5a komplementu, může nahradit kortikosteroidy v indukční léčbě pacientů s ANCA asociovanou vaskulitidou : komentář2017 | First Faculty of Medicine
- Genetically distinct subsets within ANCA-associated vasculitis2012 | First Faculty of Medicine
- ANCA-asociovaná vaskulitida a infekční endokarditida. Co je vejce a co slepice?2017 | Third Faculty of Medicine
- Nová klasifikační kritéria pro ANCA asociované vaskulitidy2022 | First Faculty of Medicine
- Avacopan - nová možnost v léčbě ANCA asociované vaskulitidy?2021 | First Faculty of Medicine
- ANCA -associated vasculitides and their treatment2009 | First Faculty of Medicine
- Treatment of ANCA associated vasculitis2008 | First Faculty of Medicine
- Asbestos and ANCA-associated vasculitides2002 | Second Faculty of Medicine
- Asbestos and ANCA associated vasculitis2001 | Second Faculty of Medicine, Central Library of Charles University
- Long-term follow-up of lymphocyte subpopulations and intracellular cytokines in patients with ANCA-associated vasculitis treated with rituximabPublication without faculty affiliation
- Plazmaferéza v léčbě ANCA asociované vaskulitidy: ano, či ne?2022 | First Faculty of Medicine
- Reduced number of endothelial progenitor cells is predictive of early relapse in anti-neutrophil cytoplasmic antibody-associated vasculitis.2009 | First Faculty of Medicine
- Exposure to SiO2 and ANCA - associated vasculitisPublication without faculty affiliation
- Exposure to SiO2 and ANCA-associated vasculitisPublication without faculty affiliation
- Asbestos and ANCA-associated vasculitides +1Publication without faculty affiliation
- Biologická léčba ANCA-asociované vaskulitidy2014 | First Faculty of Medicine
- Rituximab v udržovací léčbě ANCA asociované vaskulitidy2023 | First Faculty of Medicine
- Biological Treatment of glomerulonephritis2013 | First Faculty of Medicine
- Circulating endothelial progenitor cells in patients with ANCA-associated vasculitis2008 | First Faculty of Medicine
- Studium cytokinů a regulačních molekul u ANCA-asociované vaskulitidyPublication without faculty affiliation
- Nová doporučení EULAR pro léčbu ANCA asociované vaskulitidy2023 | First Faculty of Medicine